X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Biocon Ltd with Natco Pharma - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

BIOCON LTD vs NATCO PHARMA - Comparison Results

BIOCON LTD    Change

Biocon is India's largest biotechnology company with presence in biopharmaceuticals, custom research and clinical research. It started as an enzymes manufacturer and later evolved into an integrated biopharmaceutical company. The company has two subs... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    BIOCON LTD NATCO PHARMA BIOCON LTD/
NATCO PHARMA
 
P/E (TTM) x 85.5 15.0 569.6% View Chart
P/BV x 7.2 3.8 189.8% View Chart
Dividend Yield % 0.2 1.2 13.7%  

Financials

 BIOCON LTD   NATCO PHARMA
EQUITY SHARE DATA
    BIOCON LTD
Mar-18
NATCO PHARMA
Mar-18
BIOCON LTD/
NATCO PHARMA
5-Yr Chart
Click to enlarge
High Rs1,1881,080 110.0%   
Low Rs305671 45.4%   
Sales per share (Unadj.) Rs68.7592.1 11.6%  
Earnings per share (Unadj.) Rs7.6188.4 4.0%  
Cash flow per share (Unadj.) Rs14.0206.3 6.8%  
Dividends per share (Unadj.) Rs1.008.25 12.1%  
Dividend yield (eoy) %0.10.9 14.2%  
Book value per share (Unadj.) Rs86.3833.6 10.4%  
Shares outstanding (eoy) m600.0036.90 1,626.0%   
Bonus/Rights/Conversions ISIS-  
Price / Sales ratio x10.91.5 734.5%   
Avg P/E ratio x98.94.6 2,126.9%  
P/CF ratio (eoy) x53.44.2 1,259.2%  
Price / Book Value ratio x8.61.1 823.0%  
Dividend payout %13.24.4 302.4%   
Avg Mkt Cap Rs m447,90032,311 1,386.2%   
No. of employees `0006.14.8 127.3%   
Total wages/salary Rs m9,3113,256 286.0%   
Avg. sales/employee Rs Th6,705.84,522.5 148.3%   
Avg. wages/employee Rs Th1,514.2674.0 224.7%   
Avg. net profit/employee Rs Th736.91,439.0 51.2%   
INCOME DATA
Net Sales Rs m41,23421,848 188.7%  
Other income Rs m2,062404 510.4%   
Total revenues Rs m43,29622,252 194.6%   
Gross profit Rs m8,2919,284 89.3%  
Depreciation Rs m3,851662 581.7%   
Interest Rs m615154 399.4%   
Profit before tax Rs m5,8878,872 66.4%   
Minority Interest Rs m2130-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m1,5691,920 81.7%   
Profit after tax Rs m4,5316,952 65.2%  
Gross profit margin %20.142.5 47.3%  
Effective tax rate %26.721.6 123.2%   
Net profit margin %11.031.8 34.5%  
BALANCE SHEET DATA
Current assets Rs m41,48621,307 194.7%   
Current liabilities Rs m21,4135,920 361.7%   
Net working cap to sales %48.770.4 69.1%  
Current ratio x1.93.6 53.8%  
Inventory Days Days6473 87.3%  
Debtors Days Days94107 88.4%  
Net fixed assets Rs m50,66114,986 338.1%   
Share capital Rs m3,000369 813.0%   
"Free" reserves Rs m48,80830,353 160.8%   
Net worth Rs m51,80830,760 168.4%   
Long term debt Rs m17,8980-   
Total assets Rs m99,89737,151 268.9%  
Interest coverage x10.658.6 18.0%   
Debt to equity ratio x0.30-  
Sales to assets ratio x0.40.6 70.2%   
Return on assets %5.219.1 26.9%  
Return on equity %8.722.6 38.7%  
Return on capital %9.629.3 32.8%  
Exports to sales %00-   
Imports to sales %00-   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m12,05810,322 116.8%   
Fx outflow Rs m7,3482,978 246.7%   
Net fx Rs m4,7107,343 64.1%   
CASH FLOW
From Operations Rs m6,6214,636 142.8%  
From Investments Rs m-6,840-11,155 61.3%  
From Financial Activity Rs m-2,3976,509 -36.8%  
Net Cashflow Rs m-2,612-18 14,511.1%  

Share Holding

Indian Promoters % 40.4 52.0 77.6%  
Foreign collaborators % 20.6 1.5 1,401.4%  
Indian inst/Mut Fund % 8.4 7.8 107.1%  
FIIs % 10.7 16.6 64.3%  
ADR/GDR % 0.0 0.0 -  
Free float % 19.9 26.0 76.5%  
Shareholders   109,995 25,395 433.1%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare BIOCON LTD With:   PFIZER  GSK PHARMA  PLETHICO PHARMA  WYETH LTD  ABBOTT INDIA  

Compare BIOCON LTD With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends Over 280 Points Lower; IT and Healthcare Stocks Witness Selling(Closing)

After trading on a negative note throughout the day, share markets in India continued their downtrend during the closing hours and ended the day in red.

Related Views on News

The BSE HEALTHCARE Index Down 2% ; BIOCON LTD Among Top Losers (Market Updates)

Oct 23, 2018 | Updated on Oct 23, 2018

The BSE HEALTHCARE Index Down at 14,512 (down 2.3%). Among the top losers in the BSE HEALTHCARE Index today are BIOCON LTD, IOL CHEMICALS & PHARM. and OPTO CIRCUITS. Meanwhile, the BSE Sensex has plunged 0.7% to 34,074.

BIOCON LTD Plunges by 5%; BSE HEALTHCARE Index Down 1.1% (Market Updates)

Oct 23, 2018 | Updated on Oct 23, 2018

BIOCON LTD share price has plunged by 5% and its current market price is Rs 672. The BSE HEALTHCARE is down by 1.1%. The top gainers in the BSE HEALTHCARE Index are GLENMARK PHARMA (up 1.3%) and PFIZER (up 1.1%). The top losers is BIOCON LTD (down 5.4%)..

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Dr Reddy's: Milestone Payment Drives Sales (Quarterly Results Update - Detailed)

Feb 9, 2018

US business was hit by pricing pressure although there was growth sequentially led by new product launches.

Lupin: US market Declines Due to Higher Base Effect of FY17 (Quarterly Results Update - Detailed)

Feb 9, 2018

Price erosion in generic US drugs continues but seems to be bottoming out.

More Views on News

Most Popular

You Can Buy Select Auto Stocks Now for Big Long-Term Returns(The 5 Minute Wrapup)

Oct 17, 2018

Irrespective of the earnings hiccups, these businesses be setting new profit records.

IPO Market Feels the Heat of the Market Crash(Sector Info)

Oct 12, 2018

The sentiments in primary market have also deteriorated amid the stock market correction. Most listed IPOs of 2018 are trading below their issue price.

Stop! Read This Before You Cancel Your SIPs(Profit Hunter)

Oct 11, 2018

Read this before you stop your SIP's in equity mutual funds.

Even If IL&FS Group Brought This Correction, this is Right Time to Buy & Sit Tight!(Chart Of The Day)

Oct 12, 2018

Even if IL&FS is the culprit, it may turn out to be a hero if you buy right and sit tight.

Why Oil Cannot Be Sold to India in Rupees(Vivek Kaul's Diary)

Oct 16, 2018

Oil is bought and sold internationally in terms of dollars. And any change to this, will be attacking the exorbitant privilege of the US dollar.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

BIOCON LTD SHARE PRICE


Oct 23, 2018 (Close)

TRACK BIOCON LTD

  • Track your investment in BIOCON LTD with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

COMPARE BIOCON LTD WITH

MARKET STATS